tradingkey.logo
搜尋

Vivos Therapeutics Inc

VVOS
添加自選
0.641USD
-0.049-7.10%
收盤 05/15, 16:00美東報價延遲15分鐘
8.79M總市值
虧損本益比TTM

Vivos Therapeutics Inc

0.641
-0.049-7.10%
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-7.10%

5天

-3.58%

1月

-41.19%

6月

-72.61%

今年開始到現在

-68.42%

1年

-74.76%

TradingKey Vivos Therapeutics Inc股票評分

單位: USD 更新時間: 2026-05-15

操作建議

Vivos Therapeutics Inc當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名120/206位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為2.42。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Vivos Therapeutics Inc評分

相關信息

行業排名
120 / 206
全市場排名
273 / 4482
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Vivos Therapeutics Inc亮點

亮點風險
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
業績高增長
公司營業收入穩步增長,連續3年增長26.39%
業績增長期
公司處於發展階段,最新年度總收入17.44M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入17.44M美元
估值高估
公司最新PE估值-0.31,處於3年歷史高位
機構減倉
最新機構持股1.10M股,環比減少6.15%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉547.00股

分析師目標

基於 3 分析師
買入
評級
2.417
目標均價
+250.24%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Vivos Therapeutics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Vivos Therapeutics Inc簡介

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
公司代碼VVOS
公司Vivos Therapeutics Inc
CEOHuntsman (R. Kirk)
網址https://vivos.com/
KeyAI